We are live on ! Find out more
GILD icon

Gilead Sciences
GILD

1,626 hedge funds and large institutions have $76.4B invested in Gilead Sciences in 2020 Q2 according to their latest regulatory filings, with 161 funds opening new positions, 632 increasing their positions, 682 reducing their positions, and 161 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $75B → $76.4B (+$1.42B)

0% more first-time investments, than exits

New positions opened: 161 | Existing positions closed: 161

0% less call options, than puts

Call options by funds: $2.02B | Put options by funds: $2.02B

0.7% less ownership

Funds ownership: 79.98% → 79.28% (-0.7%)

7% less repeat investments, than reductions

Existing positions increased: 632 | Existing positions reduced: 682

1% less funds holding

Funds holding: 1,644 → 1,626 (-18)

56% less funds holding in top 10

Funds holding in top 10: 89 → 39 (-50)

Holders
1,626
Holders Change
-18
Holders Change %
-1.09%
% of All Funds
33.33%
Holding in Top 10
39
Holding in Top 10 Change
-50
Holding in Top 10 Change %
-56.18%
% of All Funds
0.8%
New
161
Increased
632
Reduced
682
Closed
161
Calls
$2.02B
Puts
$2.02B
Net Calls
-$7.91M
Net Calls Change
-$449M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$2.25B
2
BlackRock
BlackRock
New York
+$1.12B
3
California Public Employees Retirement System
California Public Employees Retirement System
California
+$473M
4
First Trust Advisors
First Trust Advisors
Illinois
+$130M
5
APG Asset Management
APG Asset Management
Netherlands
+$127M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$499M
2
N
Nuveen
North Carolina
-$465M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$378M
4
JP Morgan Chase
JP Morgan Chase
New York
-$331M
5
Renaissance Technologies
Renaissance Technologies
New York
-$278M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
1776
Walleye Capital
New York
– -$28K -380 Closed
ANBT
1777
American National Bank & Trust
Texas
– -$23K -305 Closed
PCMK
1778
Paragon Capital Management (Kansas)
Kansas
– -$22K -300 Closed
LSA
1779
Lion Street Advisors
Texas
– -$13K -169 Closed
HFM
1780
Hartford Financial Management
Connecticut
– -$10K -140 Closed
EP
1781
Elkhorn Partners
Nebraska
– -$9K -125 Closed
DTIM
1782
Danda Trouve Investment Management
Kansas
– -$7K -100 Closed
MCM
1783
McMillion Capital Management
North Carolina
– -$5K -69 Closed
MWM
1784
MBE Wealth Management
Wisconsin
– -$4K -59 Closed
MIM
1785
Macroview Investment Management
Maryland
– -$4K -50 Closed
SMFS
1786
Squar Milner Financial Services
California
– -$3K -50 Closed
WCM
1787
Wealthcare Capital Management
Virginia
– -$3K -34 Closed
NR
1788
Newfound Research
Massachusetts
– -$1K -16 Closed
BCM
1789
Birch Capital Management
Texas
– +$230 +3 New
68 69 70 71
72

GILD Hedge Fund Activity: Q2 2020 in Review

1,626 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2020, worth a combined $76.4B — up 1.9% from $75B a quarter earlier.

Fund positioning in GILD was balanced in Q2 2020: 161 funds opened new positions, 161 closed out, 632 added to existing stakes and 682 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $2.25B. The largest seller was Franklin Resources, cutting an estimated $499M.

  • 1,626 institutional investors held Gilead Sciences (GILD) as of Q2 2020, down from 1,644 in Q1 2020.
  • Funds reported $76.4B of Gilead Sciences stock for Q2 2020, up 1.9% quarter-over-quarter.
  • 161 funds opened new Gilead Sciences positions in Q2 2020 and 161 closed out, a net change of 0 holders.
  • The largest Gilead Sciences buyer in Q2 2020 was Capital Research Global Investors, an estimated $2.25B added.
  • The largest Gilead Sciences seller in Q2 2020 was Franklin Resources, an estimated $499M sold.

Based on aggregated 13F filings for Q2 2020.